Mesa Labs posts Q2 FY2027 results, issues FY2027 revenue and EBITDA guidance and launches $40 M buyback
Mesa Laboratories reported fiscal second‑quarter 2027 revenue of $62.336 million, up 2.6% on a reported basis and 2.6% organic (3.1% constant‑currency). Net income was $4.341 million, or $0.75 diluted earnings per share (GAAP). The company guided full‑year 2027 revenue of $250 million‑$255 million and adjusted EBITDA of $66 million‑$68 million, and announced a share repurchase program of up to $40 million through 2028.
Why it matters
The company notes that its FY2027 revenue guidance is below consensus estimates, which could pressure the stock. The new $40 million buyback gives the board flexibility to repurchase shares opportunistically, potentially supporting the share price (multiple materials).
Key facts
- 1Q2 FY2027 revenue was $62.336 million, up 2.6% reported and 2.6% organic (3.1% constant‑currency). tradingview.com
- 2Net income was $4.341 million, and diluted GAAP EPS was $0.75. quiverquant.com
- 3Adjusted EBITDA for the quarter was $17.317 million, a 21.1% increase on a reported basis. tradingview.com
- 4Full‑year 2027 revenue guidance is $250 million‑$255 million. quiverquant.com
- 5Full‑year 2027 adjusted EBITDA guidance is $66 million‑$68 million. quiverquant.com
- 6The board authorized a share repurchase program of up to $40 million, expiring December 31 2028. quiverquant.com
Open questions
- Material 1 reports debt repayment of $11.406 million, while material 6 states $20.1 million was repaid in the first half; both refer to total debt paid on the same basis.
Summary written by AlphAI AI Desk from 8 of 8 sources. Not investment advice. Figures are as stated by the linked sources.